Previous Close | 28.22 |
Open | 28.22 |
Bid | 27.87 x 2900 |
Ask | 27.87 x 3000 |
Day's Range | 27.69 - 28.28 |
52 Week Range | 25.20 - 37.80 |
Volume | |
Avg. Volume | 38,120,364 |
Market Cap | 157.956B |
Beta (5Y Monthly) | 0.64 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.05 |
Earnings Date | Jul 30, 2024 |
Forward Dividend & Yield | 1.68 (5.95%) |
Ex-Dividend Date | Jul 26, 2024 |
1y Target Est | 31.46 |
Pfizer stock tumbled in April and is now trending sideways despite several promising cancer drug updates. Is PFE stock now a sell?
If approved, the RSV vaccine will be Moderna's (MRNA) second approved product in the European Union.
Parnassus Investments, an investment management company, released the “Parnassus Value Equity Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here. In the first quarter, the Fund (Investor Shares) appreciated 10.17% outperforming the Russell 1000 Value Index’s 8.99%. Stock selection in the Information Technology and Communication Services sectors was the main […]